Company intelligence / Profile preview

LEM Surgical

Ownership: Private
Employees: ~30
Development stage: Preclinical

Overview

LEM Surgical has developed the Dynamis Robotic Surgical System, a next-generation multi-arm robotic platform for hard tissue surgeries, with a focus on spine. The system received FDA 510(k) clearance in April/May 2025 and will be introduced at select US hospitals this year. It features integrated navigation, real-time imaging, dynamic guidance, and broad instrument compatibility to improve surgical precision and workflow efficiency[6][7][9].

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceRobotic surgical system
Industry: Surgical Medical Devices

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on LEM Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LEM Surgical.

Explore the full profile